Oral Dosage Form New Animal Drugs; Bacitracin Methylene Disalicylate Soluble
other · Food and Drug Administration · Rule · Published 1998-07-17 · Effective 1998-07-17 · 63 FR 38474
Document
Document number
98-19026
Federal Register citation
63 FR 38474
CFR reference
21 CFR 520
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
1998-07-17
Effective date
1998-07-17
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Alpharma Inc. The supplemental NADA provides for using soluble bacitracin methylene disalicylate (BMD) powder to make a medicated drinking water for growing quail for prevention of ulcerative enteritis.